Rationale Previous studies have shown that female rats exhibit enhanced cocaine-seeking across several phases of the addiction cycle when compared to males. Drug-seeking in females is also estrous cycle dependent and inversely associated with plasma progesterone. Although sex and estrous cycle-dependent differences have been reported in the reinstatement of cocaine-seeking triggered by cocaine injections or drug-paired cues, it is not yet known what role the estrous cycle may have on stress-induced reinstatement, either alone or in combination with drug-paired cues. Objectives Here, we examined male and female rats for reinstatement of extinguished cocaine-seeking produced by cocaine-paired cues or the stress-activating drug, yohimbine. Methods Male and female Sprague-Dawley rats selfadministered intravenous cocaine (0.5 mg/kg/infusion) paired with a light+tone stimulus for 10-14 days. Lever responding was then allowed to extinguish, with subsequent reinstatement testing occurring 30 min following an injection of yohimbine (1.25 or 2.5 mg/kg, intraperitoneal) or vehicle either in the presence or absence of the conditioned stimulus. Results While males and females showed similar cue-and yohimbine-induced reinstatement (3-4 times over "No Cue"-vehicle responding), combining these stimuli resulted in a robust enhancement in cocaine-seeking in both groups, with a greater increase in females (10-12 vs. 14-15 times over "No Cue"-vehicle responding for the males and females, respectively). When examined as a function of the estrous cycle, females in proestrus demonstrated higher levels of responding during yohimbine+cues reinstatement. Conclusions This cycle-dependent enhanced sensitivity to stress enhancement of cocaine-paired cues may generalize to greater relapse susceptibility under stressful conditions.
Introduction
Abundant evidence has shown that significant gender differences exist in cocaine addiction. Although men are more likely to have a cocaine abuse or dependence disorder (see Brady and Randall 1999 for review), women begin using cocaine at an earlier age (Chen and Kandel 2002; Weiss et al. 1997 ) and progress more rapidly from casual use to the development of a dependence disorder (O'Brien and Anthony 2005; Westermeyer and Boedicker 2000) . Differences also exist between men and women in terms of relapse to cocaine use. For example, women tend to have shorter cocaine-free periods (Griffin et al. 1989; Kosten et al. 1996) , with some reports indicating an enhanced likelihood to relapse (Hyman et al. 2008; McKay et al. 1996) following exposure to stressful stimuli/life events or depression, factors that have been implicated as the leading cause of relapse in humans (see Sinha 2009 for review). However, reports of gender differences in relapse in abstinent addicts following exposure to cocaine-associated environmental stimuli have been mixed, with some reports indicating more (Robbins et al. 1999) , less (Avants et al. 1995) , or equal (Negrete and Emil 1992) susceptibility in women relative to men. Neurophysiological differences have also been demon-strated in men and women following exposure to stressful stimuli (Li et al. 2005) or cocaine-paired cues (Kilts et al. 2004) .
Similar to clinical findings, sex differences have been reported for cocaine-related behaviors in laboratory animals. Relative to males, female rats demonstrate enhanced locomotor activity to acute cocaine injections and greater behavioral sensitization after repeated cocaine administration (Hu and Becker 2003; van Haaren and Meyer 1991) . Moreover, females acquire conditioned place preference (CPP) more rapidly and at lower cocaine doses than male rats (Russo et al. 2003) . In selfadministration studies, females not only more readily acquire cocaine self-administration, they also demonstrate faster rates of acquisition than males (Hu et al. 2004; Lynch and Carroll 1999) . Greater motivation for cocaine reward is also evident in that females exhibit higher responding (but not intake) than males on short-access (2 h/day) schedules of reinforcement Kippin et al. 2005) , enhanced cocaine intake on long access (6 h/day) schedules of reinforcement (Lynch and Taylor 2004; Roth and Carroll 2004) , and higher breakpoints on progressive ratio schedules of reinforcement (Mello et al. 2007; Roberts et al. 1989) . In animal models of relapse, females exhibit greater cocaine-seeking not only during early withdrawal (Anker and Carroll 2010; Fuchs et al. 2005; Kippin et al. 2005) , but also following protracted forced abstinence (Kerstetter et al. 2008) . While female rats reinstate slightly less or equal to males following exposure to cocaine-associated cues Kerstetter et al. 2008) , females show greater cocaineprimed (Kippin et al. 2005; and stress-induced reinstatement (Anker and Carroll 2010) than males. Taken together, these data suggest that females may exhibit greater motivation for cocaine than males across all phases of the addiction cycle (see Lynch et al. 2002 for review) .
Growing evidence suggests that sex differences may be mediated at least in part by cyclic ovarian hormone changes across the menstrual cycle in human and non-human primates (see Evans and Foltin 2010 for review) or the estrous cycle in rodents (see Festa and Quinones-Jenab 2004 for review) . Relative to women during the luteal phase, women in the follicular phase report an enhancement in the subjective effects of cocaine (Evans et al. 2002; Sofuoglu et al. 1999) and D-amphetamine (Justice and de Wit 1999; White et al. 2002 ). An enhancement in motivation for cocaine as seen by higher progressive ratio breakpoints has been reported in female monkeys during the follicular phase, relative to the late luteal phase (Mello et al. 2007 ). In rats, females in vaginal estrus exhibit enhanced cocaine-seeking during selfadministration Roberts et al. 1989) , early extinction , protracted withdrawal (Kerstetter et al. 2008) , and reinstatement (Feltenstein et al. 2009; Kerstetter et al. 2008; Kippin et al. 2005) .
Despite evidence showing sex differences and the impact of rodent estrous cycle stages in mediating relapse behaviors, limited data exists on how these factors may influence drug-seeking following exposure to multiple risk factors (e.g., drug-associated stimuli and stress). While evidence in male rats has demonstrated that exposure to a stressor potentiates cue-induced reinstatement of ethanol- (Liu and Weiss 2002) , heroin- (Banna et al. 2010) , and cocaine-seeking (Buffalari and See 2009; Feltenstein and See 2006) , no studies to date have examined stress and cue interactions in female rats. Here, we examined the separate and interactive effects of previously cocaine-paired stimuli and a pharmacological stressor (yohimbine) on the reinstatement of cocaine-seeking in freely cycling female rats. Yohimbine is a norepinephrine (NE) α 2 receptor antagonist that has been shown to produce stress-like responses (e.g., increases in subjective anxiety, blood pressure, and sympathetic symptoms) in humans (Charney et al. 1983; Holmberg and Gershon 1961) and to induce drug-craving in abstinent drug-dependent subjects (Stine et al. 2002) . Similarly, yohimbine produces stress activation (e.g., increases in plasma corticosterone, arterial blood pressure, heart rate, and potentiated startle response) in animals (Davis et al. 1979; Lang and Gershon 1963; Suemaru et al. 1989 ) and reinstates drug-seeking for heroin (Banna et al. 2010) , alcohol (Gass and Olive 2007; Le et al. 2005) , methamphetamine (Shepard et al. 2004) , and cocaine (Anker and Carroll 2010; Bongiovanni and See 2008; Brown et al. 2009; Feltenstein and See 2006) . We predicted that female rats would show a greater yohimbine-stress enhancement of cue reactivity than males and that this response would vary across the estrous cycle.
Materials and methods

Subjects
Aged-matched male (n=14; initial weight 250-300 g, P59-67) and female (n=47; initial weight 175-225 g, P57-74) Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA, USA) were individually housed in a temperature-and humidity-controlled vivarium on a normal 12-h light-dark cycle with the lights on at 06:00. All experimental procedures (drug self-administration, extinction, and reinstatement testing) occurred between 09:00 and 17:00. Data for the male rats consisted of a subset of animals from a previously published study (Feltenstein and See 2006) that were tested using the same protocols used for the females and included here for comparison of sex differences. Animals were given water ad libitum and maintained on 20-25 g of standard rat chow (Harlan, Indianapolis, IN, USA) per day for the duration of each experiment. Rats were habituated to the vivarium for at least 4 days prior to the start of the experiment. All experimental procedures were approved by the Institutional Animal Care and Use Committee of the Medical University of South Carolina and conformed to federal guidelines as described in the "Guide for the Care and Use of Laboratory Rats" of the Institute of Laboratory Animal Resources on Life Sciences, National Research Council.
Surgery
Rats were anesthetized using a mixture of ketamine hydrochloride and xylazine (66 and 1.33 mg/kg, respectively, IP), followed by equithesin (sodium pentobarbital 4 mg/kg, chloral hydrate 17 mg/kg, and 21.3 mg/kg magnesium sulfate heptahydrate dissolved in 44% propylene glycol, 10% ethanol solution, IP), and chronic indwelling catheters were implanted into the right jugular vein using previously described methods (Feltenstein and See 2006) . Catheter patency was maintained by flushing with 0.1 ml of 10 U/ml heparinized saline (Elkins-Sinn, Cherry Hill, NJ, USA) immediately prior to selfadministration sessions with a 0.1-ml antibiotic solution of cefazolin (Schein Pharmaceuticals, Florham Park, NJ, USA; 10 mg/ml dissolved in 70 U/ml heparinized saline) and 0.1 ml 70 U/ml heparinized saline regimen following each session. Stylets were inserted into the catheters when the rats were not connected to the infusion pumps. For assessment of catheter patency, rats occasionally received a 0.1 ml intravenous (IV) infusion of methohexital sodium (Eli Lilly, Indianapolis, IN, USA; 10 mg/ml dissolved in 0.9% physiological saline), a short-acting barbiturate that produces a rapid loss of muscle tone when administered intravenously.
Cocaine self-administration Rats lever pressed for cocaine in standard self-administration chambers linked to a computerized data collection program (MED-PC, Med Associates Inc., St. Albans, VT, USA). The chambers were equipped with two retractable levers, a white stimulus light above each lever, a tone generator, and a white house light on the wall opposite the levers. Each chamber was contained within a sound-attenuating cubicle equipped with a ventilation fan.
Rats self-administered cocaine (cocaine hydrochloride dissolved in 0.9% physiological saline; cocaine provided by the National Institute on Drug Abuse, Research Park Triangle, NC, USA) during daily 2-h sessions according to an FR1 schedule of reinforcement. At the start of each session, the catheter was connected to a liquid swivel (Instech, Plymouth Meeting, PA, USA) via polyethylene 20 tubing that was encased in steel spring leashes (Plastics One Inc., Roanoke, VA, USA). The house light signaled the initiation of the session and remained illuminated throughout the entire session. Lever presses on the active (i.e., cocaine-paired) lever resulted in a 2-s activation of the infusion pump (0.15 and 0.125 mg cocaine per 50 μl infusion for the males and females, respectively, resulting in approximately 0.5 mg/kg/infusion) and a 5-s presentation of a stimulus complex, consisting of illumination of the white stimulus light above the active lever and activation of the tone generator (4.5 kHz, 78 dB). After each infusion, responses on the active lever were recorded but resulted in no consequences during a 20-s time-out period. Inactive lever responses were also recorded but had no programmed consequences. All self-administration sessions were conducted 6 days per week to criterion (i.e., ≥10 infusions per session) for a total period of 10-14 days.
Extinction and reinstatement of cocaine-seeking
Following chronic self-administration and before the first reinstatement test, animals underwent daily 2-h extinction sessions. During each session, responses on both levers were recorded but had no consequences. Once active lever responding extinguished to criterion (i.e., a minimum of seven extinction sessions with ≤25 active lever responses per session for two consecutive days), each animal underwent six separate within-subjects tests to examine yohimbine and cue-induced reinstatement of responding. We have previously found no decrement in responding when the number of tests is limited to a total of three for a given reinstatement condition Feltenstein and See 2006; Kippin et al. 2005) . Thirty minutes prior to a reinstatement test, each rat received an IP injection of sterile distilled water (vehicle) or yohimbine hydrochloride (1.25 or 2.5 mg/kg; Sigma-Aldrich, Saint Louis, MO, USA). The doses were selected based on previous studies in rats (Feltenstein and See 2006; Le et al. 2005; Shepard et al. 2004 ) and were given in a counterbalanced order based on active lever responding during the last 3 days of cocaine self-administration. For half the animals, responses on the active lever for the first three reinstatement tests resulted in 5-s presentation of the previously cocaine-paired light+tone cues in the absence of cocaine reinforcement (i.e., "Cue" reinstatement tests), while active lever responding for the last three reinstatement tests had no programmed consequences (i.e., "No Cue" reinstatement tests). For the remaining animals, the situation was reversed. The order of yohimbine treatment for each animal was the same for both sets of reinstatement tests, and animals underwent extinction sessions between reinstatement tests until they reached criterion (i.e., ≤25 active lever responses per session for two consecutive days).
Estrous cycle monitoring
In order to ascertain estrous cycle stages, vaginal lumen samples were collected immediately prior to and following each reinstatement test. However, to habituate females to the vaginal cytology procedure, samples were taken daily across the entire experiment. Vaginal lumen samples were collected by gently flushing 30 μl of double distilled water and extracting the sample using a micropipette and 100 μl pipette tips. Samples were placed on glass slides, stained using Quick-Dip Hematology Stain (Mercedes Medical, FL, USA), examined using a light microscope set to 10× magnification, and classified according to previously published criteria (Marcondes et al. 2002) . The proestrus phase was defined as the presence of more than 75% nucleated epithelial cells. The estrous phase (note: vaginal estrus as opposed to behavioral estrus) was defined as the presence of more than 75% anucleated cornified epithelial cells. The diestrus I (also known as metestrus) phase was defined as the presence of approximately equal proportions of nucleated epithelial cells, anucleated cornified epithelial cells, and leukocytes. The diestrus II phase was defined as containing a majority of leukocytes, a minimum amount of cells, and occasional epithelia. Due to the lower number of animals from which diestrus II smears were obtained and the lack of behavioral differences between females in the diestrus I and II states, females in the two diestrus phases were combined in statistical analyses and are hereafter referred to as diestrus I/II.
Data analysis
To determine if any pre-existing sex differences existed, independent t tests were used to analyze lever responses and cocaine intake (mg/kg) during the last 3 days of cocaine self-administration, as well as the number of days of cocaine self-administration and extinction, with sex as the between-subjects factor. Mixed factors repeatedmeasures analyses of variance (ANOVA) were used to analyze lever responses during extinction with sex and session as the between-and within-subjects factors, respectively. For reinstatement testing, three-way ANOVAs were used to analyze lever responses with sex, reinstatement test condition, yohimbine dose, and estrous phase as factors, where appropriate. Significant interactions were further investigated using ANOVAs or independent t tests, where appropriate. Data points were eliminated if they were 2.5 standard deviations beyond the group mean. All post hoc analyses were conducted using Student-NewmanKeuls with the alpha set at 0.05, and only significant F or t values are presented.
Results
Cocaine self-administration and extinction
Rats readily acquired cocaine self-administration, responded preferentially on the cocaine-paired lever, and displayed stable lever responding and cocaine intake. No pre-existing differences were found between the male and female rats for active and inactive lever responding (Fig. 1) and the mean cocaine intake (mg/kg) across the last 3 days of cocaine selfadministration, as well as total number of days of cocaine self-administration (Table 1) . Inactive lever responding was uniformly very low in both males and females across all phases of the study and failed to demonstrate any substantial changes in response to yohimbine and/or cues. Thus, while inactive lever responding is shown in the figures for comparison purposes, no statistical analyses are presented.
Following the removal of cocaine reinforcement, lever responding in both males and females decreased steadily over the course of daily extinction sessions (Fig. 1) . Similar to previous studies Kippin et al. 2005) , female rats exhibited more responding on the active lever than males during early extinction; however, there was no difference between the two groups in the number of sessions required to reach the extinction criterion (Table 1) . A 2×7 ANOVA of active lever responding during the first seven extinction sessions revealed significant main effects for sex (F(1,59)=7.57, p<0.01), session (F(6,354)=52.98, p<0.001), as well as a significant sex by session interaction (F(6,354)=4.16, p<0.001). Further analyses showed that female rats responded more on the active lever than males Fig. 1 Cocaine self-administration and extinction for male (n=14) and female (n=47) rats. Left panel: average active and inactive lever responding (mean ± SEM) for the last 3 days of cocaine selfadministration. Right panel: active (large symbols) and inactive (small symbols) lever responding for the first 7 days of extinction. Significant sex differences in responding are indicated (*p<0.05) during the first, second and fifth extinction sessions (ts(59)= 2.25-2.61, ps<0.05). Moreover, one-way simple effects ANOVAs revealed a significant effect of session for the males (F(6,91)=14.96, p<0.001) and females (F(6,322)= 63.97, p<0.001), with greater active lever responding during the first session for both groups and for the second session for females (ps<0.05).
Reinstatement of cocaine-seeking
Data for both males and females were examined for possible order effects of reinstatement testing or drug treatment. Analyses failed to reveal any significant order effects of reinstatement testing ("No Cue", "Cue") or dose treatment (0, 1.25, 2.5 mg/kg yohimbine). As such, the data were collapsed within sex group and across test day order.
Compared with the "No Cue"-vehicle condition (i.e., extinction responding), yohimbine resulted in 3-5 times higher responding for both males and females under the "No Cue" reinstatement condition (i.e., stress-induced reinstatement; Fig. 2 ). Similar increases in responding were seen for both groups under the "Cue"-vehicle condition (i.e., cueinduced reinstatement). However, yohimbine+cues robustly enhanced responding in both groups, particularly in females. A 2×2×3 ANOVA of active lever responding revealed significant main effects for sex (F(1,341) =6.89, p<0.01), cue (F(1,341)=50.27, p<0.001), and dose (F(2,341)=11.96, p<0.001), as well as a significant cue by dose interaction (F (2,341)=4.02, p<0.05). The sex by cue, sex by dose, and sex by cue by dose interactions were not significant.
To further examine the cue by dose interaction, 2×3 ANOVAs of active lever responding for the male and female rats revealed significant main effects for cue (Fs (1,78-266)=39.77-68.77, ps<0.001) and dose (Fs(2,78-266)=9.77-16.63, ps<0.001), as well as significant cue by dose interactions (Fs(2,78-266) = 3.15-5.86, ps< 0.05). One-way ANOVAs for both sexes also revealed significant main effects for dose during the "No Cue" (Fs(2,38-130)= 4.63-14.04, ps<0.05) and "Cue" (Fs(2,38-136)=6.42-11.64, ps<0.05) reinstatement tests. Post hoc analyses showed significant increases after 1.25 mg/kg yohimbine during the "Cue" reinstatement test (p<0.05), and after 2.5 mg/kg yohimbine during both reinstatement tests (ps< 0.05) in the male rats, and for both yohimbine doses during each reinstatement condition in the female rats (ps<0.05). Cue-induced reinstatement was also evident in both sexes as a significant increase was seen during the "Cue" reinstatement test relative to "No Cue" (ts(26-87)=4.67-6.66, ps<0.001). Moreover, analyses for each yohimbine treatment condition revealed enhanced responding during the "Cue" reinstatement tests for both sexes (ts(24-90)= 3.40-5.20, ps<0.005). When reinstatement was examined across the different phases of the estrous cycle, an enhancement in active lever responding was noted specifically for rats in proestrus when yohimbine was combined with the previously cocainepaired cues (Fig. 3) . A 2×3×3 ANOVA of active lever responding revealed significant main effects for cue (F (1,254) = 68.95, p < 0.001), dose (F(2,254) = 16.80, p < 0.001), and estrous phase (F(2,254)=4.97, p<0.01), as well as significant cue by estrous phase (F(2,254) =4.10, p<0.05) and cue by dose (F(2,254) =5.58, p<0.005) interactions. The dose by estrous phase and cue by dose by estrous phase interactions were not significant. Post hoc analyses revealed significantly greater reinstatement for female rats in proestrus relative to those in estrus (p<0.01) or diestrus I/II (p<0.05), as well as both doses of yohimbine relative to vehicle (ps< 0.001). Based on the significant estrous phase interaction, further analyses for each estrous phase revealed significant main effects for cue (Fs(1,68-94)=18.16-35.87, ps<0.001) and dose (Fs(2,68-94)=4.08-8.71, ps<0.05) for all three estrous cycle phases. However, the cue×dose interaction was only significant for female rats in proestrus (F (2,94)=4.67, p<0.05), with post hoc analyses revealing significant yohimbine + cue reinstatement for both doses of yohimbine (ps<0.05).
Discussion
Here, we have demonstrated in rats that while both conditioned-cued or yohimbine stress-induced reinstatement showed a similar magnitude in both males and females (i.e., 3-4 times over "No Cue"-vehicle responding), combining these stimuli resulted in a robust enhancement in cocaine-seeking in both groups, but with a greater effect occurring in females (10-12 vs. 14-15 times over "No Cue"-vehicle responding for the males and females, respectively). When reinstatement in females was examined as a function of estrous cycle, rats in proestrus displayed the highest levels of responding during yohimbine + cues reinstatement. These results indicate that relative to their male counterparts, female rats show greater sensitivity to stress modulation of cue reactivity.
While a number of studies have utilized intermittent footshock (Brown and Erb 2007; Buffalari and See 2009) and yohimbine (Bongiovanni and See 2008; Feltenstein and See 2006; Kupferschmidt et al. 2009 ) as a means to study stress-induced reinstatement of drug-seeking in rodents, only one recent study has examined stress-induced reinstatement in females (Anker and Carroll 2010) . Relative to males, female rats (cycle phase not determined) showed greater yohimbine-induced reinstatement, an effect consistent with clinical data, suggesting that women are more susceptible than men to relapse to cocaine abuse following exposure to a stressor (Hyman et al. 2008; McKay et al. 1996 ). While we found higher overall levels of reinstatement for female rats in the current study, yohimbine alone (i.e., during the "No Cue" condition) did not appear to significantly increase their level of responding above males. It should be noted that while the male rats were a separate experimental cohort, we have reliably replicated the magnitude of reinstatement in males for cue (current results, 31.2±4.7; Buffalari and See 2009, 26.4±2.5; Feltenstein et al. 2007, 28.4±3.0) , yohimbine (current results, 31.1 ±8.5; Buffalari and See 2011, 23.2± 4.3; Bongiovanni and See 2008, 34.8±6.6) , and yohimbine + cue (current results, 98.6±19.5; Buffalari and See 2011, Fig. 3 Yohimbine enhancement of cue-induced reinstatement in female rats across the estrous cycle. Active (top) and inactive (bottom) lever responding (mean ± SEM) are shown for the three estrous cycle phases (estrus, diestrus I/II, proestrus) following vehicle or yohimbine injection prior to the "No Cue" or "Cue" reinstatement tests (ns =9-22). Significant differences are indicated for vehicle vs. yohimbine injection (*p<0.05) and for the "No Cue" vs. "Cue" presentation ( † p<0.05) 85.3±14.0) reinstatement, suggesting that the observed sex differences are not likely due to experimental procedure, time of year, or seasonal effects. Moreover, the overall enhanced reinstatement noted for the female rats was unlikely due to greater locomotor activity in that (a) no significant increases in inactive lever responding occurred, and (b) comparable doses of yohimbine (e.g., 2 mg/kg) have actually been shown to decrease locomotor activity (Bowes et al. 1992) . While the magnitude of yohimbine-induced reinstatement in the female groups was comparable across the two studies, the significant sex difference noted by Anker and Carroll (2010) was primarily due to levels of responding in males that were lower than those reported previously in response to yohimbine (Banna et al. 2010; Buffalari and See 2011; Shepard et al. 2004) . This discrepancy in males may involve procedural differences, including different doses of self-administered cocaine and different yohimbine injection-to-test intervals. Nonetheless, these results overall suggest that female rats may be more sensitive than males to the stress-induced reinstatement effects of yohimbine.
One interesting finding from the current study was the enhancement of stress+cues reinstatement for female rats in proestrus. While the lack of an estrous cycle effect on cueinduced reinstatement is consistent with previous work from our laboratory , the role of the estrous cycle in mediating stress or stress+cues reinstatement has never been examined. Although there were no cycle differences in stress-induced reinstatement, the enhancement in stress+cues reinstatement for proestrus rats is unique, in that higher levels of cocaine-seeking behavior (e.g., late self-administration, early extinction, cocaineprimed reinstatement, and prolonged withdrawal) have typically been noted for female rats in estrus (Feltenstein et al. 2009; Kerstetter et al. 2008; Kippin et al. 2005) . However, basal levels of adrenocorticotrophin hormone (ACTH) and corticosterone have been found to be elevated at the time of proestrus in the rat (Critchlow et al. 1963; Raps et al. 1971) . Moreover, when exposed to a stressor, these hormones are highest for females in proestrus (Pollard et al. 1975; Viau and Meaney 1991) . In that the stress system has been shown to play a critical role in cue (Goeders and Clampitt 2002) and stress (Erb et al. 1998; Le et al. 2000; Mantsch and Goeders 1999a) , but not cocaine-primed (Erb et al. 1998; Mantsch and Goeders 1999b ) reinstatement, perhaps enhanced stress hormone levels during proestrus lead to the enhancement in cue+stress reinstatement behavior. Another possible mechanism that may have contributed to this effect could include enhanced striatal DA transport (Thompson and Moss 1997) and uptake sites (Morissette and Di Paolo 1993) during proestrus. Moreover, while relatively selective for NE α 2 receptors, the affinity of yohimbine for other receptors (e.g., serotonergic 5-HT 1A and dopaminergic D 2 receptors; Millan et al. 2000) may have also contributed to this effect, in addition to an interaction with other systems, including corticotrophin-releasing factor and other neuropeptides (see Shalev et al. 2010 for review) .
In that proestrus is characterized by high estradiol levels (see Freeman 1994 for review), estradiol may also have been a contributor to the enhanced reinstatement response. Indeed, women in the luteal phase of their menstrual cycle, when estradiol levels increase (see for review), demonstrate enhanced hypothalamicpituitary-adrenal axis-mediated responses following exposure to psychological stressors (Kirschbaum et al. 1999; Tersman et al. 1991) . In female rats, estradiol replacement has been shown to reverse ovariectomy-induced deficits in ACTH and corticosterone release following an acute stressor (Viau and Meaney 1991) , as well as deficits in cocaine-mediated behaviors, including locomotor activity (Sell et al. 2000) , self-administration (Grimm and See 1997; Hu et al. 2004; Jackson et al. 2006; Lynch et al. 2001) , and reinstatement (Larson et al. 2005) . Interestingly, when combined in ovariectomized rats, progesterone reverses these effects of estradiol Jackson et al. 2006; Larson et al. 2007; Sell et al. 2000) . Furthermore, endogenous plasma levels of progesterone are inversely associated with cocaine-seeking in female rats , while progesterone pretreatment can attenuate cocaine-primed reinstatement (Feltenstein et al. 2009 ) or cocaine CPP (Russo et al. 2008) . Similar clinical results have been reported, in that stress-and cue-induced craving is reduced in women with elevated endogenous levels of progesterone (Sinha et al. 2007 ), while progesterone pretreatment decreased the subjective effects of cocaine in women (Evans and Foltin 2006; Sofuoglu et al. 2002; Sofuoglu et al. 2004 ), but not men (Sofuoglu et al. 2004; Sofuoglu et al. 2007) . Taken together, these results suggest that estradiol and progesterone may have opposing effects on cocaine-mediated reward and cocaine-seeking behaviors.
The current results support the assertion that women may be more susceptible than men to relapse to cocaine use following exposure to multiple risk factors. While suggestive, our results are limited in that they cannot fully account for the complex interactions of endogenous ovarian hormones as they fluctuate across the cycle in intact animals. It should also be noted that while estradiol may have played a role in mediating reinstatement in the current study, it is also important to note that chronic cocaine exposure has been shown to disrupt estrous cycle activity in primates and rodents (Grimm and See 1997; King et al. 1990; , with previous work in our laboratory demonstrating a decline in the estradiol peak of proestrus during and following chronic cocaine self-administration . Moreover, plasma levels of hormones do not necessarily indicate neuronal alterations that may occur in response to changes in endogenous hormone levels. For example, while data indicates that estradiol and progesterone increase and decrease limbic/striatal DA activity, respectively (Fernandez-Ruiz et al. 1990 ), these effects only occur 4 h after administration, suggesting a delayed neuronal response to alterations in ovarian hormones. Nonetheless, both preclinical and clinical data indicate that cyclic fluctuations in ovarian hormones may contribute to the motivational effects of cocaine. Future studies should be directed towards understanding how ovarian hormone levels may be used as a means to predict relapse to cocaine-seeking in humans, as well as the efficacy of various drug treatments to attenuate the likelihood of relapse in the animal model and in cocaine-dependent women.
